Welcome to BioTrends Research Group

Our Mission

BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.

By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.

 

Recent News

  • Subscribe to Recent News

    BioTrends provides an email subscription service for its news releases 
    Please click the link below to subscribe:
    Subscribe Here



  • March 2, 2010

    RHEUMATOLOGISTS HAVE PLENTY OF CHOICE AMONG BIOLOGIC AGENTS FOR RA – WHERE WILL ACTEMRA FIND ITS NICHE? Read more... Link

  • March 1, 2010

    NEW STUDY BY BIOTRENDS HIGHLIGHTS CHANGES IN THE MANAGEMENT OF GOUT AND HYPERURICEMIA AMONG RHEUMATOLOGISTS AND PRIMARY CARE PHYSICIANS

    Read more... Link

  • February 18, 2010

    STELARA IMPRESSES WITH EFFICACY DATA AND DOSING CONVENIENCE, BUT SAFETY CONCERNS LIKELY TO IMPACT NEAR TERM UPTAKE
    Read more... Link

  • February 16, 2010

    Use of AMAG’s Feraheme is on the Rise with 23% of Nephrologists Reporting Use of the Product
    Read more... Link

  • February 12, 2010

    New Report by BioTrends Research Group Will Explore the Perceptions and Expected Use of Alternative Dialysis Modalities in the US
    Read more... Link

  • January 19, 2010

    DECISION RESOURCES, INC. ACQUIRES BIOTRENDS
    Read more... Link